Nxera Pharma Co., Ltd. (TYO: 4565)

Nxera Pharma Revenue

Nxera Pharma had revenue of 9.26B JPY in the quarter ending September 30, 2024, with 178.34% growth. This brings the company's revenue in the last twelve months to 29.28B, up 136.05% year-over-year. In the year 2023, Nxera Pharma had annual revenue of 12.77B, down -18.00%.

• Revenue (ttm): 29.28B
• Revenue Growth: +136.05%
• P/S Ratio: 3.62
• Revenue / Employee: 78.70M
• Employees: 350
• Market Cap: 108.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%
Dec 31, 2020	8.84B	-884.00M	-9.09%
Dec 31, 2019	9.73B	6.18B	173.97%